BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.

Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.

Diabetes Videos

see all videos

Support clinical trials, provide research fellowships, purchase specialized equipment, and fund the creation of the “BGU Mouse.”

Donate to

Diabetes News

see all news
Wine Has Demonstrable Benefits for Type 2 Diabetes

June 1, 2016

Tags: Medical Research

A two-year BGU study shows moderate wine consumption can raise good cholesterol while lowering the bad.

Curing Diabetes: An Interview with Dr. Eli Lewis

January 15, 2016

Tags: Medical Research

Dr. Lewis discusses how he could be the person who cures diabetes once and for all.

Diabetic Foot Is Linked to Cognitive Deterioration

November 17, 2015

Tags: Medical Research

Dr. Rachel Natovich discovers this diabetes symptom can be an indicator of more severe complications.